BRIEF published on 03/10/2025 at 03:35, 1 year 3 months ago Businesses Show Interest in AI for Sustainability Amid Energy Concerns Cloud Computing Sustainability Goals AI Adoption Energy Concerns Regional Variations
BRIEF published on 03/10/2025 at 03:35, 1 year 3 months ago Les entreprises manifestent leur intérêt pour l'IA au service du développement durable dans un contexte de préoccupations énergétiques Cloud Computing Objectifs De Développement Durable Adoption De L’IA Préoccupations Énergétiques Variations Régionales
BRIEF published on 03/10/2025 at 00:05, 1 year 3 months ago CTT Pharma Joins the OTCQB Market OTCQB Market Expansion Drug Delivery CTT Pharma Dissolvable Strips
BRIEF published on 03/10/2025 at 00:05, 1 year 3 months ago CTT Pharma rejoint le marché OTCQB OTCQB Expansion Du Marché Administration De Médicaments CTT Pharma Bandes Solubles
BRIEF published on 03/09/2025 at 19:18, 1 year 3 months ago EEII AG Announces Board of Directors Reorganization Corporate Governance Leadership Change Swiss Exchange EEII AG Board Reorganization
BRIEF published on 03/09/2025 at 19:18, 1 year 3 months ago EEII AG annonce la réorganisation de son conseil d'administration Gouvernance D'Entreprise Changement De Direction Bourse Suisse EEII AG Réorganisation Du Conseil D'administration
BRIEF published on 03/08/2025 at 19:05, 1 year 3 months ago Sanofi-Aventis Reports Positive Data for Dupixent in Bullous Pemphigoid Clinical Study Dupixent Type 2 Inflammation Bullous Pemphigoid Regulatory Review
BRIEF published on 03/08/2025 at 19:05, 1 year 3 months ago Sanofi-Aventis publie des données positives sur Dupixent dans le traitement de la pemphigoïde bulleuse Étude Clinique Dupixent Pemphigoïde Bulleuse Examen Réglementaire Inflammation De Type 2
BRIEF published on 03/08/2025 at 15:20, 1 year 3 months ago Protagonist Therapeutics Unveils Promising Results for Icotrokinra in Psoriasis Treatment Clinical Trials Protagonist Therapeutics Plaque Psoriasis Icotrokinra Treatment Efficacy
BRIEF published on 03/08/2025 at 15:20, 1 year 3 months ago Protagonist Therapeutics dévoile des résultats prometteurs pour l'icotrokinra dans le traitement du psoriasis Essais Cliniques Thérapeutique Protagoniste Icotrokinra Psoriasis En Plaques Efficacité Du Traitement
Published on 06/29/2026 at 09:01, 2 hours 39 minutes ago HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 06/27/2026 at 16:50, 1 day 18 hours ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 10 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 11 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 12 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/29/2026 at 11:03, 36 minutes ago PNE successful in onshore wind energy tender on May 1, 2026
Published on 06/29/2026 at 11:00, 40 minutes ago Original-Research: MustGrow Biologics Corp. (von GBC AG): BUY
Published on 06/29/2026 at 10:46, 54 minutes ago Aroundtown SA: Release of a capital market information
Published on 06/29/2026 at 10:35, 1 hour 5 minutes ago Cherry SE Permanently Appoints Rogier Volmer as CEO, Committing to Continuity in Its Strategic Transformation
Published on 06/29/2026 at 10:56, 44 minutes ago GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
Published on 06/29/2026 at 10:56, 44 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
